Literature DB >> 8380779

Evidence for a role for protein kinase C in the stimulation of protein synthesis by insulin in swiss 3T3 fibroblasts.

G I Welsh1, C G Proud.   

Abstract

We have examined the role of protein kinase C (PKC) in the stimulation of protein synthesis by insulin using two complementary approaches. In the first, fibroblasts were pretreated with phorbol esters to down-regulate PKC. In these cells, the effects of insulin and of phorbol esters on protein synthesis were completely abolished, although serum still elicited an effect approaching that seen in control cells. Secondly, we used newly developed inhibitors of PKC which, again, blocked the effects of insulin and phorbol esters without greatly reducing the response to serum. Thus PKC apparently plays an important role in the stimulation of translation by insulin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380779     DOI: 10.1016/0014-5793(93)81300-o

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Requirement of protein kinase C zeta for stimulation of protein synthesis by insulin.

Authors:  R Mendez; G Kollmorgen; M F White; R E Rhoads
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  A sharper instrument for dissecting signalling events: a specific AGC kinase inhibitor.

Authors:  Christopher G Proud
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

3.  Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C.

Authors:  A C Newby; K Lim; M A Evans; N P Brindle; R F Booth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

4.  Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B.

Authors:  G I Welsh; C G Proud
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

Review 5.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.